HSPA5 and metabolic dysfunction-associated steatotic liver disease: This finding aligns with the fact that overexpression of Grp78/BiP in the liver and hypothalamus of DIO mice has been used therapeutically to treat MASLD and obesity by reducing adiposity and fat content in the liver [25,27,30].